Menin-MLL

Menin-MLL interaction is a drug target for leukemia treatment. Menin is a multiple endocrine neoplasia (MEN1) products which interacts with MLL (mixed lineage leukemia) in a histone methyltransferase complex.

Products for Menin-MLL

Cat.No. 产品名称 Information
GC11837 MI-136 A menin-MLL inhibitor
GC11418 MI-2
Menin-MLL inhibitor 2;Thieno[2,3-d]pyrimidine, 4-[4-(4,5-dihydro-5,5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-propyl-
An inhibitor of menin-MLL fusion protein interactions
GC10388 MI-2 (hydrochloride) An inhibitor of menin-MLL interactions
GC12199 MI-3
Menin-MLL inhibitor 3;Thieno[2,3-d]pyrimidine, 4-[4-(4,5-dihydro-5,5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-(1-methylethyl)-
An inhibitor of menin-MLL fusion protein interactions
GC12173 MI-nc (hydrochloride) A negative control for MI-2